Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMODULIN vs RESMETIROM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMODULIN vs RESMETIROM: Safety Overview

Metric REMODULIN RESMETIROM
Total FAERS Reports 696 881
Deaths Reported 144 26
Death Rate 20.7% 3.0%
Hospitalizations 500 50
Average Patient Age 52.6 yrs 58.1 yrs
% Female Patients 66.7% 65.3%
FDA Approval Date N/A Mar 14, 2024
Manufacturer N/A Madrigal Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription